We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PhRMA is claiming that the activists involved failed to legally acquire a sufficient number of signatures to submit the petition to the General Assembly. Read More
Federal efforts to protect the drug supply chain continue to bear fruit, with the FDA’s Office of Criminal Investigations announcing criminal charges for another counterfeit operation. Read More
Amgen is taking Novartis’s biosimilar division to court over alleged patent infringement for seeking FDA approval to produce a generic version of its blockbuster drug Enbrel. Read More
Amid the backdrop of the national opioid epidemic, Endo Pharmaceuticals has settled false advertising allegations concerning its promotion of the painkiller Opana ER, according to the New York Attorney General’s Office. Read More
PhRMA is firing back at an Ohio citizen ballot initiative aiming to lower drug prices, claiming in a lawsuit that the activists involved failed to legally acquire a sufficient number of signatures to submit the petition to the General Assembly. Read More
Avycaz was granted priority review for the treatment of complicated intra-abdominal infections and infections initiated by ceftazidime-nonsusceptible pathogens. Read More